Apolipoprotein C-III displacement of apolipoprotein E from VLDL: Effect of particle size

Journal of Lipid Research

Volumn 40, Issue 10, 1999, Pages 1875-1882

  Breyer, Emelita D ^a   Le, Ngoc Anh ^b   Li, Xianzhou ^b   Martinson, Deborah ^b   Brown, W Virgil ^b  

^a GEORGIA STATE UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Fast protein liquid chromatography; High density lipoprotein; Lipolysis; Lipoprotein receptor; Triglyceride rich particles

Indexed keywords

APOLIPOPROTEIN C3; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; LIPID ANALYSIS; LIPID COMPOSITION; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN LOCALIZATION;

APOLIPOPROTEIN C-III; APOLIPOPROTEINS; APOLIPOPROTEINS C; APOLIPOPROTEINS E; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GENOTYPE; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS, HDL; LIPOPROTEINS, VLDL; MALE; PROTEIN BINDING; TRIGLYCERIDES;

EID: 0032832586     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Shelburne, F., J. Hanks, W. Meyers, and S. Quarfordt. 1980. Effect of apoproteins on hepatic uptake of triglyceride emulsion in the rat. J. Clin. Invest. 65: 652-658.
2. Schonfeld, G., P. K. George, J. Miller, P. Reilly, and J. Witztum. 1979. Apolipoprotein CII and CIII levels in hyperlipoproteinemia. Metabolism: clinical and experimental. 28: 1001-1010.
3. Brezlow, J. L., J. Sasaki, A. Zeng, M. Dammerman, Y. Takada, and N. Matsunaga. 1995. An apolipoprotein CIII marker associated with hypertriglyceridemia Caucasian also confers increased risk in a West Japanese population. Hum. Genet. 95: 371-375.
4. Ginsberg, H. N., N. A. Le, I. J. Goldberg, J. C. Gibson, A. Rubinstein, P. Wang-Iverson, R. Norum, and W. V. Brown. 1986. Apolipoprotein B metabolism in subjects with deficiency of apolipoprotein CIII and A. J. Clin. Invest. 78: 1287-1295.
5. Maeda, N., H. Li, D. Lee, J. Osada, P. Oliver, and S. H. Quardfordt. 1994. Targeted disruption of the apolipoprotein CIII gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglvceridemia. J. Biol. Chem. 269: 23610-23616.
6. Aalto-Setala, K., E. A. Fisher, X. Chen, T. Chajek-Shaul, T. Hayek, R. Zechner, A. Walsh, R. Ramakrishnan, H. N. Ginsberg, and J. L. Breslow. 1992. Mechanism of hypertriglyceridemia in human apolipoprotein CIII transgenic mice. J. Clin. Invest. 90: 1889-1900.
7. Bar-Tana, J., B. Frenkel, and J. Bishara-Shieban. 1994. The effect of β, β′-tetramethylhexadecanedioic acid (MEDICA 16) on plasma very low density lipoprotein metabolism in rats: role of apolipoprotein CIII. Biochem. J. 298: 409-414.
8. Bar-Tana, J., G. Rose-Kahn, B. Frenkel, Z. Shafer, and M. Fainaru. 1988. Hypolipidemic effect of ′, ′-methyl-substituted hexadecanedioic acid (MEDICA 16) in normal and nephrotic rats. J. Lipid Res. 29: 431-441.
9. Weisgraber, K. H., T. L. Innerarity, S. C. Rall, and R. W. Mahley. 1985. Apolipoprotein E: receptor binding properties. Adv. Exp. Med. Biol. 183: 159-171.
10. Innerarity, T. L., K. S. Arnold, K. H. Weisgraber, and R. W. Mahley. 1986. Apolipoprotein E is the determinant that mediates the receptor uptake of β-very low density lipoproteins by mouse macrophages. Arteriosclerosis. 6: 114-122.
11. Wang-Iverson, P., H. N. Ginsberg, L. A. Peteanu, N. A. Le, and W. V. Brown. 1985. ApoE-mediated uptake and degradation of normal very low density lipoproteins by human monocyte macrophages: a saturable pathway distinct from the LDL receptor. Biochem. Biophys. Res. Commun. 126: 578-586.
12. Ehnholm, C., R. W. Mahley, D. A. Chapel, K. H. Weisgraber, E. Ludwig, and J. L. Witzum. 1984. Role of apolipoprotein E in the lipolytic conversion of β-very low density lipoprotein to low density lipoproteins in type III hyperlipoproteinemia. Proc. Natl. Acad. Sci. USA. 81: 5566-5570.
13. Evans, A., B. Wolfe, W. Strong, and M. Huff. 1993. Reduced lipolysis of large apoE-poor-VLDL subfractions from type IV hypertriglyceridemic subjects in vitro and in vivo. Metabolism. 42: 105-115.
14. Landis, B., F. S. Rotolo, W. C. Meyers, A. B. Clark, and S. H. Quarfordt. 1987. Influence of apolipoprotein E on soluble and heparin-immobilized hepatic lipase. Am. J. Physiol. 252: G805-G810.
15. Thuren, T., P. Sisson, and M. Waite. 1991. Activation of hepatic lipase catalyzed phosphotidylcholine hydrolysis by apolipoprotein E. Biochim. Biophys. Acta. 1083: 217-220.
16. Goldberg, I. J., N. A. Le, J. R. Paterniti, H. N. Ginsberg, F. T. Lindgren, and W. V. Brown. 1982. Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. J. Clin. Invest. 70: 1184-1192.
17. Alaupovic, P., W. J. McConathy, J. Fesmire, M. Tavella, and J. M. Bard. 1988. Profiles of apolipoproteins and apolipoprotein B-containing lipoprotein particles in dysbetalipoproteinemia. Clin. Chem. 34: B13-B27.
18. Zhang, S. H., R. L. Reddick, J. A. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258: 468-471.
19. Windler, E., and R. J. Havel. 1985. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. J. Lipid Res. 26: 556-565.
20. McConathy, W. J., J. C. Gesquiere, H. Bass, A. Tartar, J. C. Fruchart, and C-S. Wang. 1992. Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III. J. Lipid Res. 33: 995-1003.
21. Wang, C. S., W. J. McConathy, H. V. Kloer, and P. Alaupovic. 1985. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J. Clin. Invest. 75: 384-390.
22. Kinnunen, P., and C. Ehnholm, 1976. Effect of serum and C-apoproteins from very low density lipoproteins on human plasma hepatic lipase. FEBS Lett. 65: 354-357.
23. Brown, W. V., and M. L. Baginsky. 1972. Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. Biochem. Biophys. Res. Commun. 6: 375-381
24. Groot, P. H., T. J. Van Berkel, J. K. Kruijt, and L. M. Scheck. 1983. Effect of apolipoproteins E and CIII on the interaction of chylomicions with parenchymal and non-parenchymal cells from rat liver. Biochem. J. 216: 71-80.
25. Shimano, H., Y. Namba, J. Ohauga, M. Kawamura, K. Yamamoto, M. Shimad, T. Gotoda, K. Harada, Y. Yasaki, and N. Yamada. 1994. Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice. J. Clin. Invest. 93: 2215-2223.
26. Brown, M. S., K. H. Weisgraber, R. W. Mahley, J. L. Goldstein, R. C. Kowal, and J. Herz. 1990. Apolipoprotein CI modulates the interation of apolipoprotein E with β-migrating very low density lipoprotein (β-VLDL) and inhibits binding of β-VLDL to low density lipoprotein receptor-related protein. J. Biol. Chem. 265: 22453-22459
27. Shepherd, J., J. R. Patsch, C. J. Packard, A. M. Gotto, and O. D. Taunton. 1978. Dynamic properties of human high density lipoprotein apoproteins. J. Lipid Res. 19: 383-389.
28. Rubinstein, A., J. C. Gibson, H. N. Ginsberg, and W. V. Brown. 1986. In vitro metabolism of apolipoprotein E. Biochim. Biophys. Acta. 879: 355-361.
29. Gibson, J. C., and W. V. Brown, 1988. Effect of lipoprotein lipase and hepatic triglyceride lipase activity on the distribution of apolipoprotein E among the plasma lipoproteins. Atherosclerosis. 73: 45-55.
30. Eisenberg, S., J. R. Patsch, J. T. Sparrow, A. M. Gotto, and T. Olivecrona. 1979. Very low density lipoprotein. Removal of apolipoprotein CII and CIII during lipolysis in vitro. J. Biol. Chem. 254: 12603-12608.
31. Blum, C. B. 1982. Dynamics of apolipoprotein E metabolism in humans. 1982. J. Lipid Res. 23: 1308-1316.
32. Tornoci, L., C. A. Scheraldi, X. Li, H. Ide, I. J. Goldberg, and N-A. Le. 1993. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins. J. Lipid Res. 34: 1793-1803.
33. Bukberg, P. R., N-A. Le, H. N. Ginsberg, J. C. Gibson, A. Rubinstein, and W. V. Brown. 1985. Evidence for non-equilibrating pools of apolipoprotein C-III in plasma lipoproteins. J. Lipid Res. 26: 1047-1057.
34. Jackson, R. L., and G. Holdsworth. 1986. Isolation and properties of human apolipoproteins CI, CII and CIII. Methods Enzymol. 128: 288-297.
35. Innis-Whitehouse, W., X. Li, W. V. Brown, and N-A. Le. 1998. An efficient Chromatographie system for lipoprotein fractionation using whole plasma. J. Lipid Res. 39: 679-690.
36. Miller, S. A., D. D. Dykes, and H. F. Polesky. 1988. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215.
37. Bolla, M. J., L. Haddad, S. E. Humphries, A. F. Winder, and I. N. M. Day. 1995. High-throughput method for determination of apolipoprotein E genotypes with use of restriction digestion analysis by microplate array diagonal gel electrophoresis. Clin. Chem. 41: 1599-1604.
38. 2-associated C-apoproteins. J. Lipid Res. 26: 26-37.
39. Fredenrich, A., L. M. Giroux, M. Tremblay, L. Krimbou, J. Davignon, and J. S. Cohn. 1997. Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions. J. Lipid Res. 38: 1421-1432.
40. Rensen, P. C., N. Herijgers, M. H. Netscher, S. C. J. Meskers, M. Van Eck, and T. J. C. van Berkel. 1997. Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo. J. Lipid Res. 38: 1070-1084.
41. Tikkanen, M. J., T. G. Cole, K. S. Hamh, E. S. Krul, and G. Schonfeld. 1984. Expression of apolipoprotein B epitopes in very low density lipoprotein subfractions: studies with monoclonal antibodies. Arteriosclerosis. 4: 138-146.
42. Havel, R. J., Y. S. Chao, E. E. Windler, L. Kotite, and L. S. S. Guo. 1980. Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia. Proc. Natl. Acad. Sci. USA. 77: 4349-4353.
43. Nikoulin, I. R., and L. K. Curtiss. 1998. An apolipoprotein E synthetic peptide targets to lipoproteins in plasma and mediates both cellular lipoprotein interactions in vitro and acute clearance of cholesterol-rich lipoproteins in vivo. J. Clin. Invest. 101: 223-234.
44. Ebara, T., R. Ramakrishnan, G. Steiner, and N. S. Shacter. 1997. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. J. Clin. Invest. 99: 2672-2681.
45. De Silva, H. V., S. J. Lauer, J. Wang, W. S. Simonet, K. H. Weisgraber, R. W. Mahley, and J. M. Taylor. 1994. Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E. J. Biol. Chem. 269: 2324-2335.